Company news

Accuray Incorporated news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Accuray Announces Approval of the Tomo® C Radiation Treatment Delivery System by China's National Medical Products Administration

October 2, 2023

Accuray Opens New Global Training Center at Madison, WI Headquarters to Advance Radiotherapy Treatment Techniques Amid Growing Demand for Precision Cancer Care

September 17, 2023

Accuray to Host Investor Day at ASTRO on October 3, 2023

September 13, 2023

Accuray Receives FDA Clearance for VitalHold™ on the Radixact® System; Breast Cancer Treatment Option Will Also Be Available in the EU Market

August 8, 2023

Accuray to Report Fiscal Year-End 2023 Financial Results on August 9, 2023

July 25, 2023

Accuray Incorporated Announces Its Addition to the Russell 2000® Index

June 25, 2023

Accuray Reports Fiscal 2023 Third Quarter Financial Results

April 25, 2023

Accuray to Report Third Quarter Fiscal 2023 Financial Results on April 26, 2023

April 12, 2023

Robert C. Kill Joins Accuray Board of Directors

January 31, 2023

Accuray Reports Fiscal 2023 Second Quarter Financial Results

January 31, 2023

Accuray to Report Second Quarter Fiscal 2023 Financial Results on February 1, 2023

January 17, 2023

Accuray Announces First Patient Treatments in New Zealand With the CyberKnife® System, the World's Only Robotic Radiation Therapy Delivery Device

January 16, 2023

Accuray Reports Fiscal 2023 First Quarter Financial Results

November 1, 2022

Accuray Announces Tomo® C Registration Submission to China's National Medical Products Administration

October 31, 2022

Accuray to Report First Quarter Fiscal 2023 Financial Results on November 2, 2022

October 18, 2022

Accuray and C-RAD Unveil Automated Breast Cancer Treatment Package for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting

October 12, 2022

Accuray Announces First CyberKnife® Systems in Africa, Providing a New Option and Hope for Potentially Life-Saving Radiation Treatments for More Cancer Patients

September 29, 2022

Dr. Seth Blacksburg Joins Accuray as VP, Chief Medical Officer Americas Region

September 13, 2022

Accuray Reports Fourth Quarter and Fiscal 2022 Financial Results

August 9, 2022

Accuray to Report Fiscal Year-End 2022 Financial Results on August 10, 2022

July 26, 2022

Accuray Appoints Franco N. Palomba as VP, Chief Accounting Officer & Controller

June 14, 2022

Accuray and Limbus AI Inc. Partner to Leverage Limbus' Innovative AI-driven Technology to Enhance Accuray Adaptive Radiotherapy Solutions

June 1, 2022

Accuray Appoints Sandeep Chalke as SVP, Chief Commercial Officer

May 16, 2022

Accuray ClearRT™ Helical Fan-Beam kVCT Imaging Wins "Best New Technology Solution for Oncology" MedTech Breakthrough Award

May 4, 2022

Accuray Reports Fiscal 2022 Third Quarter Financial Results

April 26, 2022

Accuray Announces Suzanne Winter, President, Promoted to President and CEO; Joshua Levine Will Retire as CEO and Board Member

April 26, 2022

Accuray to Report Third Quarter Fiscal 2022 Financial Results on April 27, 2022

April 12, 2022

10-Year Data Shows Accuray CyberKnife® System Provides Long-Lasting Relief of the Excruciating Pain Caused by Trigeminal Neuralgia

March 30, 2022

Accuray Reports Fiscal 2022 Second Quarter Financial Results

January 25, 2022

Accuray CyberKnife® Robotic Radiosurgery System Receives Shonin Approval to Treat Trigeminal Neuralgia, a Chronic Pain Condition Affecting a Facial Nerve

December 14, 2021

Accuray CyberKnife® Robotic Radiotherapy Platform Expands Range of Neurological Indications That Can Be Effectively Treated With Stereotactic Radiosurgery

November 9, 2021

Accuray Reports Fiscal 2022 First Quarter Financial Results

November 2, 2021

Accuray Announces Preliminary First Quarter Fiscal 2022 Financial Results and Raises FY22 Revenue Guidance to range between $420 million to $427 million

October 20, 2021

Accuray Unveils VOLO™ Ultra, the Latest Innovation for the Radixact® System, at ASTRO 2021

October 18, 2021

Accuray to Report First Quarter Fiscal 2022 Financial Results on November 3, 2021

October 12, 2021

Accuray to Host ASTRO Analyst & Investor Meeting on October 25, 2021

October 11, 2021

Mika Nishimura Joins Accuray Board of Directors

August 22, 2021

Accuray Reports Fourth Quarter and Fiscal 2021 Financial Results

August 10, 2021

Accuray to Report Fiscal Year-End 2021 Financial Results on August 11, 2021

July 13, 2021

Accuray Announces Promotion of Suzanne Winter to President

June 21, 2021

Accuray Expands CyberKnife® System Versatility with Integration of RaySearch's RayStation Treatment Planning System

June 15, 2021

Accuray Expands Commercialization of ClearRT™ Helical Fan-Beam kVCT Imaging for the Radixact® System with CE Mark Certification

June 9, 2021

Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules

May 5, 2021

Accuray Announces New $120 Million Credit Facility

May 5, 2021

Accuray Announces Convertible Notes Exchange and Subscription

May 5, 2021

Accuray Reports Third Quarter Fiscal 2021 Financial Results

April 26, 2021

Accuray Appoints Jean-Philippe Pignol, M.D., Ph.D. as Chief Medical & Technology Officer

April 25, 2021

Accuray Receives Shonin Approval for ClearRT™ Helical kVCT Imaging, CE Mark Expected by End of June; Expands Commercial Launch

April 21, 2021

Accuray to Report Third Quarter Fiscal 2021 Financial Results on April 27, 2021

April 12, 2021

Accuray Appoints Healthcare Executive and Physician Byron C. Scott to Board of Directors

February 18, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 37 decks. Every deck is listed under its year.